Document is current

Any future updates will be listed below

A phase II trial of Ifosfamide combination with recommended supportive therapy for recurrent SCLC in second-line and heavily treated setting

Crossref DOI link: https://doi.org/10.1007/s00280-017-3497-0

Published Online: 2017-12-12

Published Print: 2018-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark